Innovation Fund Denmark
Innobooster
“Our collaboration with Innvite was completely by the book – strictly professional and based on trust”
Charlotte Vedel
Founder, Lactobio
Innovation Fund Denmark
“Our collaboration with Innvite was completely by the book – strictly professional and based on trust”
Charlotte Vedel
Founder, Lactobio
Today, more than 20% of all children worldwide live with eczema (atopic dermatitis). Eczema causes periods of constant itching, where giving in to the itching only worsens the symptoms and can result in sequelae.
In new case studies, the Lactobio product has shown significant anti-inflammatory and antibacterial effects within 14 days – normally this can take up to several weeks.
In 2022, Lactobio has received an important Innobooster grant from the Innovation Fund Denmark to intensify the work with promising bacterial strains, for the treatment of eczema.
The Innobooster project runs until the end of Q3 2023. The goal is to create a new ground-breaking cream-based treatment for eczema.